The Data Developers
Financial & Market Access

Medicare Part D Drug Spending Intelligence

Medicare Part D spending 2019-2023 with 5-year trend, CAGR, average spend per claim, total beneficiary counts, and manufacturer-level breakdown. IRA negotiation priority scoring.

5K+ drugs Annual Updated 2026-07-01

Overview

Medicare Part D spending 2019-2023 with 5-year trend, CAGR, average spend per claim, total beneficiary counts, and manufacturer-level breakdown. IRA negotiation priority scoring.

Analyze spending trend, beneficiary exposure, and program-specific cost trajectory without building CMS crosswalks.

Join NDC, HCPCS, RxCUI, manufacturer, and canonical drug identifiers through validated bridge tables.

Prioritize IRA negotiation, ASP pressure, and acquisition-cost signals using pre-computed scoring fields.

Trace every financial metric back to the public CMS source file and refresh batch.

Source authority

Centers for Medicare & Medicaid Services — Part D Spending

Freshness

Last refreshed 2026-07-01

Annual

Coverage

5K+ drugs

2 delivery tables